Tekla Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,065	Closed	-$2.69M	–	179
2023 Q1	$2.69M	Hold	67,065	–	–	0.1%	108
2022 Q4	$3.11M	Hold	67,065	–	–	0.12%	97
2022 Q3	$2.78M	Buy	67,065 +22,700	+51%	+$940K	0.11%	102
2022 Q2	$2.65M	Sell	44,365 -96,361	-68%	-$5.75M	0.1%	107
2022 Q1	$10.2M	Hold	140,726	–	–	0.36%	60
2021 Q4	$11.8M	Hold	140,726	–	–	0.38%	61
2021 Q3	$12.7M	Buy	140,726 +6,136	+5%	+$553K	0.41%	58
2021 Q2	$12.8M	Buy	134,590 +37,110	+38%	+$3.54M	0.42%	61
2021 Q1	$11.1M	Hold	97,480	–	–	0.38%	69
2020 Q4	$13.5M	Hold	97,480	–	–	0.47%	61
2020 Q3	$8.01M	Hold	97,480	–	–	0.3%	77
2020 Q2	$7.63M	Hold	97,480	–	–	0.29%	74
2020 Q1	$4.33M	Hold	97,480	–	–	0.2%	95
2019 Q4	$4.16M	Hold	97,480	–	–	0.16%	121
2019 Q3	$4.17M	Buy	97,480 +59,000	+153%	+$2.52M	0.18%	93
2019 Q2	$2.44M	Sell	38,480 -38,478	-50%	-$2.44M	0.1%	125
2019 Q1	$5.34M	Hold	76,958	–	–	0.22%	92
2018 Q4	$3.35M	Hold	76,958	–	–	0.14%	104
2018 Q3	$5.88M	Hold	76,958	–	–	0.21%	86
2018 Q2	$5.92M	Sell	76,958 -71,600	-48%	-$5.5M	0.22%	88
2018 Q1	$7.58M	Hold	148,558	–	–	0.29%	75
2017 Q4	$6.89M	Hold	148,558	–	–	0.27%	71
2017 Q3	$7.91M	Buy	148,558 +21,250	+17%	+$1.13M	0.28%	66
2017 Q2	$7.91M	Buy	127,308 +38,908	+44%	+$2.42M	0.29%	66
2017 Q1	$5.99M	Hold	88,400	–	–	0.23%	80
2016 Q4	$6.22M	Hold	88,400	–	–	0.26%	70
2016 Q3	$6.27M	Hold	88,400	–	–	0.24%	77
2016 Q2	$4.32M	Hold	88,400	–	–	0.18%	88
2016 Q1	$5.6M	Hold	88,400	–	–	0.24%	81
2015 Q4	$9.92M	Hold	88,400	–	–	0.36%	60
2015 Q3	$8.51M	Buy	88,400 +28,400	+47%	+$2.74M	0.31%	68
2015 Q2	$6.14M	Buy	+60,000	New	+$6.14M	0.22%	74